Raising the bar for market authorisation of new drugs

BMJ. 2012 Aug 7:345:e4261. doi: 10.1136/bmj.e4261.

Authors

Huseyin Naci¹, Jonathan Cylus, Sotiris Vandoros, Azusa Sato, Kumar Perampaladas

Affiliation

¹ LSE Health, London School of Economics and Political Science, London, UK.

PMID: 22872693
DOI: 10.1136/bmj.e4261

No abstract available

MeSH terms

Drug Approval / legislation & jurisprudence*
Drug Discovery / legislation & jurisprudence*
Drug Industry / legislation & jurisprudence
Drug Industry / trends
Europe
Evidence-Based Medicine
Legislation, Drug / trends
Marketing of Health Services / legislation & jurisprudence*
Treatment Outcome
United States
United States Food and Drug Administration